top of page

Japan Introduces OTC Medicine Collection Outlet Registration from May 2027

2 days ago
5 min read

Japan will introduce a new registration system allowing businesses to operate collection points for over-the-counter (OTC) medicines under the remote management of licensed pharmacies or authorised medicine retailers.


The new framework takes effect on 20 May 2027, following amendments to the Pharmaceuticals and Medical Devices Act enacted on 21 May 2025 (Act No. 37 of 2025). Its implementation date and detailed requirements have been established through Cabinet Orders Nos. 209 and 210 and MHLW Ordinances Nos. 110 and 142 of 2026.


On 13 November 2026, the Ministry of Health, Labour and Welfare (MHLW) also approved a regulatory sandbox demonstration by Fuji Electric involving automated OTC medicine collection equipment.


These developments may create new opportunities for pharmacy groups, retailers and businesses developing medicine collection services in Japan.


Regulatory background


Under Japan's Pharmaceuticals and Medical Devices Act (薬機法), OTC medicines are generally sold by licensed pharmacies or authorised medicine retailers (店舗販売業者), subject to requirements concerning professional supervision and pharmaceutical safety.


The amendments establish a separate framework for registered medicine collection outlets (登録受渡店舗), allowing customers to collect OTC medicines from premises operated by third parties.


The collection outlet does not independently sell medicines. The sale remains the responsibility of the commissioning pharmacy or authorised retailer, while the outlet handles their physical handover to customers.


1. Registration requirements for collection outlets


Businesses other than licensed pharmacies or authorised medicine retailers wishing to operate OTC medicine collection outlets must obtain registration.


Registration is required for each individual outlet and must be renewed every six years.


The competent authority is the prefectural governor or, where applicable, the mayor of a city with a public health centre or the head of a special ward.


Applications must identify the operator, the premises, the categories of OTC medicines handled, the handover hours, the responsible outlet manager and the commissioning pharmacy or retailer.


Supporting documents include a floor plan, the corporate registry certificate where applicable, documentation concerning the responsible person and operational arrangements, a copy of the commissioning seller's licence, the collection-service agreement and the prescribed operating procedure manuals.


Premises and operational requirements


Registered collection outlets must comply with specific structural and operational standards, including:

  • A floor area of approximately 6.6 m² or more;

  • Lighting of at least 60 lux in the medicine handover area;

  • Appropriate storage facilities, including lockable medicine storage;

  • A responsible outlet manager or designated employee on duty during handover hours;

  • Communication arrangements allowing customers to contact the commissioning pharmacy or retailer.


Additional requirements apply to medicine storage, access to the premises and the operation of automated collection equipment.


Collection outlets cannot independently provide pharmaceutical consultations and must refer relevant enquiries to the commissioning seller.


They must also display prescribed information about their operations and the commissioning pharmacy or retailer.


Licensed pharmacies and authorised medicine retailers that themselves perform collection services on behalf of another seller are deemed registered under Article 29-5(8), although other applicable requirements continue to apply.


Same-prefecture restriction


Under the initial framework, collection outlets and their commissioning pharmacies or retailers must be located within the same prefecture.


This is both a registration condition and a restriction on the relevant contractual arrangements.


MHLW has explained that the restriction applies for the time being (当面の間). Broader geographical coverage may be considered following an assessment of the system after implementation, but no date for lifting the restriction has been established.


This requirement will be particularly relevant to businesses planning collection networks across Japan.


2. Separate permission requirements for pharmacies and retailers


Registration of a collection outlet does not, by itself, authorise a pharmacy or retailer to commission medicine handovers.


The commissioning pharmacy or retailer must obtain the relevant permission from the competent authority before commencing such arrangements.


This permission can be obtained in connection with an initial pharmacy or retail business licence application or through a separate application by an existing licence holder.


The commissioning business must appoint a handover manager (受渡管理者) responsible for supervising the collection arrangements.


Depending on the medicines handled, the manager must be a pharmacist or a registered seller meeting prescribed professional experience requirements. For Class I medicines, a pharmacist is generally required, subject to a limited exception for experienced registered sellers supported by a pharmacist.


The commissioning business must also establish operating procedures, provide appropriate training, supervise the collection outlet and conduct audits.


Where a pharmacy or retailer commissions two or more registered collection operators, it must assess the number of outlets its management arrangements can adequately supervise.


Additional communication facilities, including video-call equipment, are required where designated abuse-prevention medicines are handled under the applicable conditions.


3. Applications before May 2027


The amended Act expressly permits applications for registration before the new system takes effect.


Under Article 13(7) and (8) of the amending Act's Supplementary Provisions, competent authorities may grant registrations in advance, with those registrations becoming effective on 20 May 2027.


Separate transitional provisions also permit advance applications and permission decisions for commissioning pharmacies and retailers.


Prospective operators may therefore prepare their premises, contractual arrangements and application documentation ahead of implementation.


However, the practical filing arrangements should be confirmed with the competent local authority, as MHLW has indicated that further operational guidance will be issued.


4. Regulatory sandbox approval for automated medicine collection


On 13 November 2026, MHLW approved a demonstration proposed by Fuji Electric Co., Ltd. under Article 8-2 of the Industrial Competitiveness Enhancement Act.


The demonstration involves dedicated OTC medicine collection equipment installed as part of an existing licensed pharmacy, under professional supervision.


The approved scope covers Class I, designated abuse-prevention medicines (指定濫用防止医薬品), designated Class II, Class II and Class III OTC medicines. Guidance-required medicines (要指導医薬品) are excluded.


Under the approved plan, pharmacists and other qualified personnel assess whether collection is appropriate before authorising the equipment to release the medicines.


The equipment is intended for collection rather than medicine selection or payment.


The approval concerns this specific demonstration and does not constitute general authorisation for other businesses to operate automated medicine collection systems.


The demonstration should therefore be distinguished from the registration framework that will take effect in May 2027.


Practical implications for businesses


The new system may create opportunities for international pharmacy groups, retail chains and businesses providing medicine collection infrastructure.


However, businesses must distinguish between operating a registered collection outlet and conducting the underlying pharmaceutical sales activity.


Companies planning multiple outlets should assess the applicable premises requirements, staffing arrangements, same-prefecture restriction and the commissioning pharmacy's supervisory capacity.


Businesses considering automated collection equipment should also review the requirements concerning professional supervision, staff availability and equipment management.


Recommended next steps


Businesses considering OTC medicine collection services in Japan should first determine whether they intend to act as the licensed seller, the collection outlet operator or a technology provider.


They should then assess the applicable permission and registration requirements, identify suitable premises and commissioning partners, and prepare the necessary documentation.


As applications may be submitted before the new system takes effect, prospective operators can begin preparing for the 20 May 2027 implementation date.


Further guidance from MHLW and the competent local authorities should be monitored before filing.


Official Japanese sources

bottom of page